Sana Biotechnology Inc vs TORM plc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while TORM plc trades at $29.89 (market cap $2.99B). The key difference: TORM plc is far larger — about 3.4× Sana Biotechnology Inc's market cap, and TORM plc pays a 9.62% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | TRMD | |
|---|---|---|
Market Cap | $873.84M | $2.99B |
Sector | Health | Technology |
52-Week High | $5.92 | $34.87 |
52-Week Low | $2.68 | $17.50 |
Enterprise Value | $848.03M | $3.88B |
Dividend Yield | — | 9.62% |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →